Plain-English translation of NCT06018935 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows 500 patients with ovarian cancer (including related cancers of the fallopian tube and peritoneum) as they receive treatment at the hospital. The study tracks how well different treatments work, including surgery, chemotherapy, and a maintenance medication called PARPi, and watches for side effects and complications. By gathering this information over time, researchers hope to understand what helps patients recover best and live longer, healthier lives.
Right now, doctors have many treatment options for ovarian cancer, but we don't fully understand which approaches work best for which patients, or how to best manage side effects and help patients stay healthy long-term. This study aims to fill those gaps by carefully tracking real patients' experiences with the medication and other treatments.
You would receive your standard cancer treatment (surgery, chemotherapy, and possibly maintenance medication) at the hospital as planned. Alongside your regular care, the research team would collect information about your treatment, recovery, side effects, and quality of life through regular check-ins and follow-up visits. This helps doctors track how you're doing and understand what factors influence how well patients respond to treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Sponsor
Sichuan Cancer Hospital and Research Institute
Enrollment target
~500 participants
Started
June 2024
Primary completion
September 2025
Sex
Female only
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dengfeng Wang, Learned scholar
Sichuan Cancer Hospital and Research Institute